The content provided on this site, including linked pages, is intended solely for educational purposes and should not be construed as medical or professional advice or recommendations. Consultation with your healthcare provider(s) or qualified professional(s) is needed for any information and content on this site and linked information on other sites.
Why should we empower ourselves with
Alzheimer's and dementia knowledge?
This knowledge is essential because it affects:
|
1 in 20
|
|
The Alzheimer's MythThese startling statistics impact our family members, friends, patients, clients, and colleagues. Contrary to common belief, Alzheimer's and other dementias are not due to old age. They are caused by brain pathological changes that increase with age. Unfortunately, the average diagnosis is made 2 to 6 years after initial symptoms appear.
This causes much family suffering, safety risks, and a tremendous financial stress on the US healthcare system. Baby Boomers through centennials are driving demographic curves like never seen before in history. |
A Word from Susan...
Curious about “senility" (described as such in the earliest years of my career as a CNA, medical-surgical RN, and student NP), it has become my utmost passion to share my expertise on the topic.
Sample some of my Alzheimer’s work below. Allow it to help you in guiding outpatients, nursing facility residents, caregivers, care partners, and families. Here you can explore Alzheimer’s and geropsychiatric programs.
Sample some of my Alzheimer’s work below. Allow it to help you in guiding outpatients, nursing facility residents, caregivers, care partners, and families. Here you can explore Alzheimer’s and geropsychiatric programs.
Alzheimer's Disease Continuing Education Courses
Powered by Clinical Care Options
The following courses are specifically for healthcare professionals.
|
Medical Minute 1:
Diagnosing
Alzheimer's Disease Alzheimer’s disease can be difficult to differentiate from other types of dementia, especially in the early stages. In this Medical Minute, healthcare professionals will learn valuable strategies to help them feel empowered in their differential diagnosis of Alzheimer’s disease.
0.25 CME Available
Released 10/20/23 |
Medical Minute 2:
Relating
Alzheimer’s Disease Pathophysiology to Treatment Efforts As knowledge on the pathophysiology of Alzheimer’s disease has progressed, so has the mechanism of action of treatments. In this Medical Minute, learn about the progression of Alzheimer’s disease and the novel disease-modifying therapies that target its underlying pathophysiology.
0.25 CME Available
Released 10/27/23 |
Medical Minute 3:
Innovations in Alzheimer's Disease: Amyloid-Targeted Therapies
Amyloid-targeted therapies have recently entered the treatment paradigm for early Alzheimer’s disease—an exciting development as these agents are disease-modifying therapies, rather than symptom-targeting therapies, for a progressive neurodegenerative disease. In this Medical Minute, healthcare professionals will learn valuable information about these agents and their use in clinical practice.
0.5 CME Available
Released 10/20/23 |
.
|
Clinical Thought ArticleTopic: Expert Guidance on Screening and Diagnosing Early AD (Released 9/19/23)
A huge component of improving the outlook for patients with mild cognitive impairment or Alzheimer’s disease is early identification. Learn what tools are available to assist in detecting and confirming signs of dementia or cognitive dysfunction and understand the ever-evolving treatment landscape of Alzheimer’s disease. |
|
Susan Scanland, MSN, CRNP, GNP-BC, CDP
CEO & Founder, Dementia Connection® Clarks Summit, PA 18411 [email protected] C: 570-575-0195 | F: 570-300-2228 |
|
